(2021) Bupropion-induced acute dystonia in a patient with bulimia nervosa: A case report. Journal of family medicine and primary care. pp. 1034-1036. ISSN 2249-4863
Full text not available from this repository.
Abstract
Bupropion is taken as an antidepressant for treatment of major depressive disorders, treatment of sexual side effects of selective serotonin reuptake inhibitors, and as a smoking cessation aid, however, it may result in adverse effects such as nausea, dry mouth, headache, insomnia, dizziness, anxiety, tremor, and constipation. We investigate the case of a 34-year-old woman with bulimia nervosa where acute dystonia was induced by bupropion in 8 months. Following this diagnosis and after normal tests and MRI results, the patient was advised to discontinue bupropion intake. In the follow-up done 2 weeks later, 3 months later, and 6 months later, no signs of acute dystonia was observed. A physician who administers dopamine blocking agents must be aware of the prevalence of and the risk factors for acute dystonia and also the way of prevention and treatment.
Item Type: | Article |
---|---|
Keywords: | Anxiety bupropion induced acute dystonia bulimia nervosa dizziness side effects insomnia General & Internal Medicine |
Page Range: | pp. 1034-1036 |
Journal or Publication Title: | Journal of family medicine and primary care |
Journal Index: | WoS |
Volume: | 10 |
Number: | 2 |
Identification Number: | https://doi.org/10.4103/jfmpc.jfmpc₁₁₇₃₂₀ |
ISSN: | 2249-4863 |
Depositing User: | Mr mahdi sharifi |
URI: | http://eprints.ssu.ac.ir/id/eprint/28589 |
Actions (login required)
View Item |